date,title,source
Oct-17-18,2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report,Motley Fool
Oct-19-18,"The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke",Zacks
Oct-22-18,"Why Tesaro, Inc. Is Tanking Today",Motley Fool
Oct-22-18,Here's Why Clovis Oncology Dropped as Much as 21.2% Today,Motley Fool
Oct-22-18,AstraZeneca to Present New Data Demonstrating Breadth of Research Portfolio in Renal Disease at ASN Kidney Week 2018,Business Wire
Oct-23-18,[$$] AstraZeneca Adds Cancer Drugs to Pipeline,The Wall Street Journal
Oct-23-18,AstraZeneca digs deeper into cancer with Innate stake,Reuters
Oct-23-18,[$$] AstraZeneca deepens partnership with Innate Pharma,Financial Times
Oct-23-18,AstraZeneca to buy 9.8 percent stake in France's Innate Pharma,Reuters
Oct-24-18,Here's Why Tesaro Inc. Dropped 13.8% Today,Motley Fool
Oct-25-18,Today's Research Reports on Trending Tickers: AstraZeneca and Eli Lilly and Company,ACCESSWIRE
Oct-25-18,[$$] The London Report: dollar earners buoy FTSE 100,Financial Times
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"Report: Exploring Fundamental Drivers Behind Manulife Financial, Baozun, AstraZeneca, Insight Enterprises, Albireo Pharma, and Mobile TeleSystems OJSC  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-30-18,"AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal",Reuters
Oct-30-18,[$$] European Corporate Roundup,The Wall Street Journal
Oct-30-18,[$$] AstraZeneca to Sell Drugs Rights for $815M,The Wall Street Journal
Nov-01-18,European businesses demand urgent Brexit deal after meeting May,Reuters
Nov-01-18,The Landmark DECLARE-TIMI 58 Cardiovascular Outcomes Trial of FARXIGA in Patients with Type 2 Diabetes to Be Featured at AHA 2018,Business Wire
Nov-02-18,"Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus",Zacks
